Antiproliferative activity of kinetin riboside on HCT-15 colon cancer cell line
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
160 0
SM ISO690:2012
RAJABI, Mehdi, GORINCIOI, Elena, SANTANIELLO, Enzo. Antiproliferative activity of kinetin riboside on HCT-15 colon cancer cell line. In: Nucleosides, Nucleotides and Nucleic Acids, 2012, vol. 31, nr. 6, pp. 474-481. ISSN 1525-7770. DOI: https://doi.org/10.1080/15257770.2012.681825
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Nucleosides, Nucleotides and Nucleic Acids
Volumul 31, Numărul 6 / 2012 / ISSN 1525-7770 /ISSNe 1532-2335

Antiproliferative activity of kinetin riboside on HCT-15 colon cancer cell line

DOI:https://doi.org/10.1080/15257770.2012.681825

Pag. 474-481

Rajabi Mehdi12, Gorincioi Elena34, Santaniello Enzo2
 
1 University of Eastern Piedmont, Novara,
2 University of Milan,
3 University of Milano-Bicocca,
4 Institute of Chemistry of the Academy of Sciences of Moldova
 
 
Disponibil în IBN: 13 mai 2023


Rezumat

Cytokinins and cytokinin nucleosides are purine derivatives with potential anticancer activity both in vitro and in vivo. N6-furfuryladenosine (kinetin riboside, KR) displays antiproliferative and apoptogenic activity against various human cancer cell lines and has recently been shown to suppress tumor growth in murine xenograft models of human leukemia and melanoma. In this study, we demonstrate that KR is able to inhibit the proliferation in HCT-15 human colon cancer cells in a dose-dependent manner with a concentration of 2.5 ̀M, which causes 50% inhibition of cell viability. The cell cycle analysis by flow cytometry showed that KR arrested cell cycle progression in the S Phase by blocking through G2/M and G0/G1 phase in HCT-15 colon cells. Moreover, suppression of clonogenic activity occurs after exposure to KR at a concentration of 2.5 μM for HCT-15. 

Cuvinte-cheie
apoptosis, Cell cycle analysis, HCT-15 colon cancer, Kinetin riboside, Proliferation